Clinical Trial Update: A Phase III Clinical Study of Cabergoline Tablets Compared With Bromocriptine Mesylate Tablets [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial comparing cabergoline tablets with bromocriptine mesylate tablets for hyperprolactinemia is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperprolactinemia

Drugs mentioned

• Bromocriptine mesylate (bromocriptine mesylate)
• CABERGOLINE (CABERGOLINE)

Snippet

Sponsor: Changchun GeneScience Pharmaceutical Co., Ltd. | Conditions: Hyperprolactinemia | Phase 3 | Status: RECRUITING